Home / News / Global Transplant Diagnostic Market is expected to grow with a CAGR of 9.12%during 2016-2022 – Brisk Insights

Global Transplant Diagnostic Market is expected to grow with a CAGR of 9.12%during 2016-2022 – Brisk Insights

According to a recently published report, the global Transplant Diagnostic Market is expected to grow with a CAGR of 9.12%during 2016-2022. The global transplant diagnostic market is segmented on the basis of application,product, technology, end user, and geography. The report on global transplant diagnostic market forecast2016-2022 (by application, products, technology, end user,and geography) provides detailed overview and predictive analysis of the market.

Full report available global Transplant diagnostic market forecast 2016-2022 (by application, product, technology, end user, and geography) report at http://www.briskinsights.com/report/transplant-diagnostic-market

Theincreasing number of cases of chronic disordersand organ failures, such as- liver, pancreas, lungs, kidney, and heart; in which, the organ has to be relocatedor organ transplantation is needed, are driving the transplant diagnostic market. In addition, increasing investments in R&D in HLA(Human Leukocyte Antigen) typing leading to the development of new and innovative products; and, thegrowing solid organs, soft tissues, and stem cell transplant procedure are the major drivers that are predicted to boost the global transplant diagnostic market. Limited medical reimbursements for organ donation and transplantation procedures in many countries is acting as a major restraint for the market. In the emerging countries, the healthcare infrastructure is improving day by day,creating new growth opportunity for the transplant diagnostic market.

The product segment is divided into three sub-segments, among which the software and services sub-segment is displaying the fastest growth in the product segment of global transplant diagnostic market. Similarly, the end user segment is further divided in four sub-segments, of which the hospitals and transplant centershave dominated the market in 2014; and, the growth of this market is attributed to the rising demand of organ transplants.

Geographically, North Americahad the dominant market share in 2014. And, as the healthcare market in the region is increasing continuously, along with the patient’s affordability the market of North America is expected to continue to lead the global transplant diagnostic market. Asia Pacific is the fastest growing region during the forecast period, because of the huge potential of the market with increasing awareness and affordability of expensive medical treatments due to increasing disposable per capita income.

Scope of the Report

  1. Global Transplant Diagnostic Market by Application 2012-2022 ($ Million)
    1.1. Diagnostic Applications
    1.2. Research Applications
  2. Global Transplant Diagnostic Market by Products & Services 2012-2022 ($ Million)
    2.1. Reagents and Consumables
    2.2. Instruments
    2.3. Software and Services
  3. Global Transplant Diagnostic Market by Technology 2012-2022 ($ Million)
    3.1. Molecular Assays
    3.1.1. PCR-Based Molecular Assays
    3.1.1.1. Sequence-Specific Primer (SSP)-PCR
    3.1.1.2. Sequence-Specific Oligonucleotide (SSO)-PCR
    3.1.2. Sequencing-Based Molecular Assay
    3.1.2.1. Sanger Sequencing
    3.1.2.2. Next-Generation Sequencing (NGS)
    3.2. Non-Molecular Assay
    3.2.1. Serological Assay
    3.2.2. Mixed Lymphocyte Culture (MLC) Assay
  4. Global Transplant Diagnostic Market by End User2012-2022 ($ Million)
    4.1. Hospitals and Transplant Centers
    4.2. Commercial Service Providers
    4.3. Research Laboratories and Academic Institutes
  5. Global Transplant Diagnostic Market Regional Outlook 2012-2022($ Million)
    5.1. North America
    5.2. Europe
    5.3. Asia Pacific
    5.4. Rest of the world
  6. Company Profiles
    6.1. Abbott laboratories, Inc. (U.S.)
    6.2. Ad Sigma-Aldrich
    6.3. Affymetrix, Inc. (U.S.)
    6.4. Bio-Rad Laboratories, Inc. (U.S.)
    6.5. F. Hoffmann-La-Roche Limited. (Switzerland)
    6.6. Illumina, Inc. (U.S.)
    6.7. Immucor, Inc. (U.S)
    6.8. Linkage Biosciences
    6.9. Luminex Corporation. (U.S.)
    6.10. Olerup SSP AB (Sweden)
    6.11. Qiagen N.V. (Netherlands)
    6.12. Thermo Fisher Scientific, Inc. (U.S.)

 

Release ID: 2823

About Brisk Insights

Check Also

400-400

Worldwide Survey: Contraceptives Sales Market 2016 to 2022 Size, Share, analysis,Trends and Forecast By Acute Market Reports

Report Description: Notes: Sales, means the sales volume of Contraceptives Revenue, means the sales value ...